Clinical Trial Update: Efficacy and Tolerability of Carbamazepine CR in Diabetic Neuropathy Pain [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy and tolerability of Carbamazepine CR for diabetic neuropathy pain, sponsored by Novartis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• Carbamazepine CR (carbamazepine)

Snippet

Sponsor: Novartis | Conditions: Neuropathic Pain | Phase 4 | Status: COMPLETED